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The vitamin K-dependent -glutamyl carboxylase
binds an 18-amino acid sequence usually attached as a
propeptide to its substrates. Price and Williamson
(Protein Sci. (1993) 2, 1997–1998) noticed that residues
495–513 of the carboxylase shares similarity with the
propeptide. They suggested that this internal propep-
tide could bind intramolecularly to the propeptide bind-
ing site of carboxylase, thereby preventing carboxyla-
tion of substrates lacking a propeptide recognition
sequence. To test Price’s hypothesis, we created nine
mutant enzyme species that have single or double mu-
tations within this putative internal propeptide. The
apparent Kd values of these mutant enzymes for human
factor IX propeptide varied from 0.5- to 287-fold when
compared with that of wild type enzyme. These results
are consistent with the internal propeptide hypothesis
but could also be explained by these residues participat-
ing in propeptide binding site per se. To distinguish
between the two alternative hypotheses, we measured
the dissociation rates of propeptides from each of the
mutant enzymes. Changes in an internal propeptide
should not affect the dissociation rates, but changes to a
propeptide binding site may affect the dissociation rate.
We found that dissociation rates varied in a manner
consistent with the apparent Kd values measured above.
Furthermore, kinetic studies using propeptide-contain-
ing substrates demonstrated a correlation between the
affinity for propeptide and Vmax. Taken together, our
results indicated that these mutations affected the
propeptide binding site rather than a competitive inhib-
itory internal propeptide sequence. These results agree
with our previous observations, indicating that residues
in this region are involved in propeptide binding.
The vitamin K-dependent -glutamyl carboxylase is a poly-
topic integral membrane protein that resides in the endoplas-
mic reticulum (1). It catalyzes the post-translational modifica-
tion of a number of vitamin K-dependent proteins (e.g. the
coagulation proteins prothrombin, factor VII, factor IX, factor
X, protein S, protein C, and protein Z) (2, 3). Other known
vitamin K-dependent proteins are the bone-related proteins
osteocalcin and matrix Gla protein, the growth arrest protein
Gas 6, and four proteins of unknown function: proline-rich Gla
proteins I and II and TMG proteins 3 and 4 (4–9). Vitamin
K-dependent carboxylase utilizes the substrates: reduced vita-
min K, carbon dioxide, oxygen, and a propeptide-containing
substrate. Multiple glutamic acid residues of the polypeptide
substrate, within about 40 residues of the propeptide, are usu-
ally modified to -carboxyglutamate during a single binding
event (10).
The primary interaction between the vitamin K-dependent
carboxylase and its substrates is mediated by the 18-amino
acid propeptide sequence (11, 12), which in all known vitamin
K-dependent proteins, except for matrix Gla protein, is re-
moved prior to secretion. The role of the substrate’s propeptide
is to anchor it to the carboxylase for a time sufficient for
multiple carboxylations (13). In addition to its role in anchoring
the substrate to the carboxylase, binding of the propeptide to
carboxylase also significantly stimulates the incorporation of
CO2 into non-propeptide-containing substrates (12, 14).
We have recently demonstrated that, at 20 °C, the affinities
(measured as Ki) of the various propeptides for carboxylase
vary from about 5 nM for factor X to greater than 500 M for
bone Gla protein (15). We further demonstrated that a consen-
sus propeptide bound considerably tighter to carboxylase than
any known naturally occurring propeptide (16).
Knobloch and Suttie (12) found that the propeptide of factor
X decreased the Km and increased the Vmax of the carboxylase
for the small Glu-containing substrate FLEEL.1 They proposed
that this stimulation resulted in propeptide-containing sub-
strates being selectively modified by the carboxylase. Based
upon this suggestion, Price and Williamson (17) searched the
carboxylase for a sequence that could compete with the propep-
tide for its substrates. They searched the 24-amino acid se-
quence of exon 3 of the human matrix Gla protein and found a
sequence within the carboxylase homologous with the propep-
tide sequence. Based upon the earlier observation that the
propeptide stimulated incorporation of CO2 into FLEEL, they
postulated that residues 495–513 of the carboxylase functioned
as an internal propeptide, and could bind intramolecularly to
the propeptide binding site. They further suggested that this
intramolecular interaction would prevent carboxylation of pro-
teins lacking the propeptide docking sequence. To test this
hypothesis, they proposed that one should reduce the affinity of
the internal propeptide for the propeptide binding site by mu-
tating the highly conserved phenylalanine that corresponded to
16 of the propeptide. With our knowledge that the consensus
sequence propeptide binds tightly to carboxylase (16), we set
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out to test Price’s hypothesis. We hypothesized that if we made
the putative internal propeptide sequence more (or less) like
the consensus sequence, the intramolecular binding should be
tighter (or weaker) and that it would require higher (or lower)
concentrations of propeptide to stimulate CO2 incorporation
into the small substrate FLEEL. To test the hypothesis that
there was an internal propeptide, we made nine single or
double mutations in the putative internal propeptide of human
carboxylase and tested their effect on the carboxylase molecule.
Our results strongly suggest that the proposed internal propep-
tide contributes to the propeptide binding site rather than to a
self-regulatory domain.
EXPERIMENTAL PROCEDURES
Materials—All chemicals were reagent grade. FLEEL was purchased
from Bachem (Philadelphia, PA). CHAPS was from Pierce. Leupeptin,
pepstatin, aprotinin, and phenylmethylsulfonyl fluoride were from
Roche Molecular Biochemicals. Vitamin K1 was from Sigma and was
reduced to hydroquinone (KH2) as previously described (18). 1,2-Dio-
leoyl-sn-glycero-3-phosphocholine was from Avanti Polar Lipids (Ala-
baster, AL). Bovine serum albumin (fraction V, heat shock) was from
Roche Molecular Biochemicals. Fluorescein-labeled and unlabeled pep-
tides, based on the human FIX propeptide, proFIX19, and consensus
sequences (16) were chemically synthesized, purified, and verified by
ion spray mass spectrometry by Chiron Mimotopes (Clayton, Victoria,
Australia). In the synthesis of the fluorescein-labeled propeptides, 5(6)-
carboxyfluorescein was conjugated to the amino terminus of the propep-
tide. Purity of all peptides was determined by mass spectrometry and
high pressure liquid chromatography and was found to be 95%. The
pSK vector was from Stratagene (La Jolla, CA). The pVL1392 vector
was from Pharmingen (San Diego, CA). The BacVector 3000 baculoviral
DNA was from Novagen (Madison, WI). Sf9 insect cells were obtained
from the Lineberger Cancer Center at the University of North Carolina
(Chapel Hill, NC). High Five insect cells were provided by Dr. Thomas
Kost of Glaxo Wellcome. HPC4 antibody affinity resin was obtained
from Dr. Charles Esmon (Oklahoma Medical Research Foundation). SP
Sepharose was from Amersham Biosciences. All other materials were
from Sigma and were reagent grade.
Expression and Purification of Recombinant Wild Type and Mutant
Carboxylase—The cDNA of human -glutamyl carboxylase was cloned
into the pSK vector and was modified to the desired sequence by
site-directed mutagenesis as previously described (19). All constructs
having carboxylase sequence were flanked by sequences coding for the
FLAG (DYKDDDDK) tag at their amino termini and by the HPC4 tag
(EDQVDPRLIDGK) (20) at their carboxyl termini. The presence of
these tags does not appear to alter the properties of the carboxylase
molecule; i.e. its activity and kinetic properties are not measurably
different from the wild type enzyme. The DNA sequence of each con-
struct was determined in its entirety by the DNA sequence facility at
the University of North Carolina at Chapel Hill. The engineered DNAs
were subcloned into the pVL1392 vector, and the proteins were ex-
pressed in baculovirus-infected High Five cells as previously described
(15). Solubilization and isolation of microsomes from High Five cells
were done as previously described (15). All enzyme preparations were
purified to homogeneity (purity  98%) as previously described (15).
Determining Protein Concentrations—The enzyme preparations
were preincubated with 0.067 M iodoacetamide at 37 °C for 15 min to
eliminate the effects of dithiothreitol on the protein assay reagents. The
total protein concentrations (including both active and inactive enzyme)
were determined by using Bio-Rad detergent-compatible protein assay
kits and IgG protein standard following the supplier’s protocol. The
active concentration of our enzyme preparations was determined by
titration with FproCon as described below.
Fluorescence Anisotropy—All of the measurements were performed
in a 400-l fluorimetric quartz curette (Starna Cells, Atascadero, CA) at
4.5 °C in a final sample volume of 300 l. Enzymes and propeptides
were preincubated for 1 h in standard buffer containing 100 mM MOPS
(pH 7.5), 166 mM NaCl, 3.5% glycerol, 6.3 mM dithiothreitol, 66 M
EDTA, 0.1% 1,2-dioleoyl-sn-glycero-3-phosphocholine, 0.28% CHAPS,
and 0.4% bovine serum albumin. The fluorescence intensity of plane
polarized light at four mutually perpendicular polarizing filter settings
(IVV, IVH, IHV, and IHH) of samples was measured with an SLM-Aminco
8100 spectrofluorimeter equipped with Glan-Thompson polarizing fil-
ters in the excitation and emission beams; each point represents the
average of six readings. The excitation and emission wavelengths were
490 and 525 nm, respectively. Anisotropy was calculated from the four
measured intensities as previously described (21, 22).
Titration for Active Enzyme Concentrations—The concentration of
active enzyme in a purified carboxylase preparation was determined by
measuring the number of propeptide binding sites in the preparation.
Previous work indicates a correlation between the presence of a propep-
tide binding site and catalytic activity and indicates that only active
enzyme can bind propeptide. Therefore, a measurement of the concen-
tration of propeptide binding sites in a carboxylase preparation is a
measurement of the concentration of the active fraction of enzyme (22).
For each sample, the fraction of FproCon bound to carboxylase was
determined from the anisotropy value, and the concentration of propep-
tide binding sites (active enzyme) was determined from the fraction
bound versus [carboxylase] plot as previously described (22). Briefly,
when appropriate conditions are chosen (concentration of FproCon 
Kd), anisotropy of FproCon increases linearly with increasing carboxyl-
ase concentration to about 75% saturation. The equivalence point of
active carboxylase concentration was determined from the intersection
of a linear regression of the data points (up to 75% fraction bound) with
a horizontal line determined from the saturation value (100% fraction
bound). All enzyme concentrations used in the calculation of kinetic
constants were the active enzyme concentrations determined by its
ability to bind propeptide (22).
Off Rate Measurement—The time course of FproFIX19 release from
wild type and mutant carboxylases was measured essentially as de-
scribed previously (22). For the wild type or P495V/Q497A, F496A, and
Q503R carboxylases, 10 nM active enzyme was preincubated with 25 nM
FproFIX19 in standard buffer at 4.5 °C for 1 h to allow the mixture to
come to equilibrium. A 350-fold excess of unlabeled proFIX19 was
added at time 0. The sample was added to a microcuvette and was
placed into the sample holder of the SLM-Aminco 8100 spectrofluori-
meter. Intensity measurements were taken at 20-s intervals as previ-
ously described (22), and the anisotropy at each data point was calcu-
FIG. 1. The alignment of the proposed internal propeptide
region with the consensus human propeptide and the corre-
sponding region of the mutations used. Yellow residues on a black
background represent mutations that make the internal propeptide less
like the consensus sequence. Residues mutated to be more like the
consensus sequence are shown in black on a yellow background. Resi-
dues Ser510 and Trp512 were mutated to test our alternative hypothesis
and are shown with a brown background.
FIG. 2. Determining the apparent Kd of proFIX19 for wild type
and mutant carboxylase. Carboxylation was measured by 14CO2
incorporation as described under “Experimental Procedures,” and reac-
tions were performed, at varied proFIX19 concentrations, with 20 nM
active wild type enzyme (), V502A (E), Q503R (f), Q503N (), S510A
(Œ), or W512A (‚). The fraction of bound enzyme was determined as
described under “Experimental Procedures.” Only results for mutants
that have altered affinities for proFIX19 are shown.
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lated (21). For the mutants V502A, V502A/P504Q, S510A, and W512A,
100 nM active carboxylase was premixed with 100 nM FproFIX19 to
achieve a starting anisotropy value significantly above base line. For
the mutants Q503N and P504Q, 50 nM carboxylase was premixed with
100 nM FproFIX19. All off rate experiments were carried out at 4.5 °C,
and all data were well fitted to a model of propeptide release described
by a single exponential decay,
at  ai  afexp(kt)  af (Eq. 1)
where at is the anisotropy at time t, ai and af are the anisotropies at
initial and final time, respectively, k is the first-order rate constant, and
t is time. Time course data were fitted to Equation 1 by minimizing the
parameters ai, af , and k. The changes in fluorescent intensity of Fpro-
FIX19 upon binding to the wild type and all mutant enzymes were
found to be insignificant and did not affect the fraction bound, so rate
constants could be accurately determined directly from the anisotropy
data (22).
Determining the Apparent Kd of proFIX19 for Wild Type and Mutant
Carboxylase—Reactions were performed with 20 nM active carboxylase
in a buffer containing 25 mM MOPS (pH 7.5), 500 mM NaCl, 0.16%
CHAPS, 0.16% phosphatidylcholine, 222 M vitamin K hydroquinone, 6
mM dithiothreitol, 10 Ci of NaH14CO3 (specific activity, 54 mCi/mmol),
and 1.5 mM FLEEL. The desired concentration of proFIX19 was in-
cluded in each reaction. Reactions were at 20 °C for 30 min as previ-
ously described (19). The fraction of bound enzymes (fb) was determined
using the following equation: fb  (Vobs  Vf)/(Vsat  Vf). The Vobs, Vf ,
and Vsat refer to FLEEL carboxylation velocity in the presence of a
certain concentration of proFIX19, in the absence of proFIX19, and in
the presence of saturating proFIX19 respectively. The apparent Kd of
wild type and mutant carboxylase was determined from fb as previously
described (22, 23).
Kinetic Studies—For kinetic studies of FLEEL carboxylation, 20 nM
active carboxylase was used for each reaction. Reactions were per-
formed in the presence or absence of saturating proFIX19 at 20 °C for
30 min and were carried out as described above, except that the con-
centration of the substrate FLEEL was varied from 0 to 40 mM for
V502A and S510A and from 0 to 20 mM for other mutants in the absence
of proFIX19. In the presence of saturating proFIX19, the concentration
of the substrate FLEEL was varied from 0 to 4.8 mM. For kinetic studies
of propeptide-containing substrates, FIX Q/S, consisting of residues
18 to 41 of human FIX with mutations at 4 (Arg 3 Gln), 1 (Arg
3 Ser), and 19 (Met3 Ile), was used. Previous studies have shown that
there is no significant difference in kinetic properties between a wild
type substrate and the FIX Q/S (24). Twenty nM active carboxylase was
used for each reaction. Reactions were performed at 20 °C for 60 min in
a buffer containing 25 mM MOPS (pH 7.5), 500 mM NaCl, 0.16%
CHAPS, 0.16% phosphatidycholine, 222 M vitamin K hydroquinone, 6
mM dithiothreitol, and 10 Ci of NaH14CO3. The concentration of the
propeptide-containing substrate FIX Q/S, was varied from 0 to 2500 nM.
On Rate Measurement—To measure the rate of FproCon to carbox-
ylase, 150 nM of wild type, V502A, S510A, or W512A enzyme was added
to standard buffer containing 10 nM FproCon at time 0. 20 s after
adding enzymes, the anisotropy values were measured at 5-s intervals.
The anisotropy at each time point was converted to fraction bound of
FproCon as previously described (21, 22). Our previous results indicate
that once FproCon bound to wild type, V502A, S510A, or W512A car-
boxylase, it would not come off within 12 h (data not shown). Thus, the
contributions to the changes of anisotropy in our experiments of the
release of FproCon from carboxylase can be ignored. All measurements
were performed at 4.5 °C, and all data were fitted to a pseudo-first order
reaction equation,
c  b1  expkat (Eq. 2)
where c represents the concentration of carboxylase-FproCon complex,
b is the total concentration of FproCon, a is the total concentration of
enzyme, t is time in seconds, and k is the rate constant.
RESULTS
Mutations—To investigate the function of the putative inter-
nal propeptide region of carboxylase, we made several muta-
tions in the region identified by Price and Williamson. These
FIG. 3. Kinetic studies of FLEEL carboxylation. Carboxylation of
FLEEL, measured by 14CO2 incorporation as described under “Experi-
mental Procedures,” was performed in the absence of (a) or in the
presence of saturating proFIX19 (b). Reactions contained 20 nM of
active wild type enzyme (), V502A (E), Q503R (f), Q503N (), S510A
(Œ), or W512A (‚). Only results for mutants that have altered affinities
for proFIX19 are shown.
TABLE I
The apparent Kd for proFIX19 and the maximal stimulated FLEEL carboxylation velocities for wild type and mutant carboxylase
Enzyme Apparent Kd for proFIX19 Difference Maximal stimulated activity Difference
nM -fold pmol 14CO2/min/pmol enzyme -fold
Wild type 7.3  0.5 1.0 29.1  1.1 1.0
P495V/Q497A 9.4  1.3 1.3 26.2  2.6 0.9
F496A 8.8  0.7 1.2 27.1  1.6 0.9
V502A 53.7  3.1 7.4 28.9  1.3 1.0
V502A/P504Q 51.2  4.9 7.0 28.2  1.2 1.0
Q503N 24.4  1.7 3.3 28.0  1.2 1.0
Q503R 4.2  0.1 0.6 26.6  0.4 0.9
P504Q 11.7  1.5 1.6 28.0  1.6 1.0
S510A 2200  50 287 25.9  0.9 0.9
W512A 1770  58 242 28.9  1.2 1.0
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mutations were designed to make the putative internal propep-
tide sequence either more like or less like a consensus propep-
tide sequence. The consensus sequence, which was determined
by selecting the most prevalent amino acid at each position in
all known propeptides, binds to the carboxylase with an affinity
much higher than any known, naturally occurring, propeptide
(16). Fig. 1 demonstrates the alignment of the proposed inter-
nal propeptide region with the consensus human propeptide
and the corresponding region of the mutations used in this
paper. If region 495–513 contains an internal propeptide, then
mutations rendering it more like the consensus sequence (e.g.
V502A, Q503N, P504Q, and the double mutations P495V/
Q497L and V502A/P504Q) would be expected to cause stronger
intramolecular interactions with the propeptide binding site.
These mutations would cause a decrease in the apparent affin-
ity for the propeptide. Conversely, mutations making the re-
gion diverge from the consensus sequence (e.g. F496A and
Q503R) should reduce the binding between the propeptide
binding site and the putative internal propeptide, resulting in
an apparent increased affinity for propeptide. S510A and
W512A were mutated to test the alternative hypothesis.
Determining the Apparent Kd of proFIX19 for Wild Type and
Mutant Carboxylase—The free propeptide of the vitamin K-de-
pendent proteins has been shown to stimulate the rate of car-
boxylation of FLEEL (12); therefore, the apparent Kd of propep-
tide can be determined by measuring the velocities of FLEEL
carboxylation at varied propeptide concentrations. Fig. 2 shows
a plot of enzyme fraction bound versus proFIX19 concentra-
tions. The apparent Kd of proFIX19 for wild type enzyme was
7.3  0.5 nM, whereas the apparent Kd for mutant enzymes
varied from 4.2  0.1 to 2200  50 nM (Table I). However,
P495V/Q497A and F496A were not significantly different from
wild type enzyme (Table I). It is notable that the maximum
stimulated rates of FLEEL carboxylation were comparable for
all mutants and wild type enzyme.
FLEEL Carboxylation—The binding sites for glutamate and
propeptide appear to be functionally linked (12, 14, 22). We
therefore investigated the effects of these mutations on the
kinetics of CO2 incorporation into FLEEL. Kinetic constants for
FLEEL carboxylation were determined in the presence or ab-
sence of saturating proFIX19. In the absence of proFIX19,
Q503R (which has the highest affinity for proFIX19) was found
to have the lowest Km (1.90 mM). In contrast, the Km values for
FLEEL of V502A, Q503N, and S510A vary from 4.7 to more
than 30 mM and are higher than the 3.33 mM of wild type
enzyme. The affinity of these mutants (V502A, Q503N, Q503R,
and S510A) for FLEEL appears to increase or decrease in
parallel with their affinities for proFIX19 (Fig. 3a and Table
II). As shown in Fig. 3, although the affinities in the absence of
propeptide (inferred from the Km values toward FLEEL) are
different from that of wild type enzyme, their Vmax values are
similar to that of the wild type enzyme in the presence of
saturating proFIX19. The kinetic constants for FLEEL carbox-
ylation in the presence of saturating proFIX19 were also deter-
mined. Fig. 3b demonstrates that, in the presence of saturating
proFIX19, the Km and Vmax values of all mutants were similar
to wild type enzyme. It is notable that, except for S510A and
W512A, the Vmax values of most mutations and the wild type
enzyme were consistently increased 3-fold when the mutant
enzymes were saturated with proFIX19 (Table II).
The Off Rate of FproFIX19 from Carboxylase—Thus far, our
data are consistent with Price’s hypothesis (17). However, we
might obtain the same effects if we were mutating the propep-
tide binding site instead of an internal propeptide. We realized
that if mutations were in the proposed internal propeptide site,
then, neglecting linkage, they should not affect the off rate of a
bound propeptide. If, however, the region mutated was part of
the propeptide binding site, the off rate might be affected. As
shown in Fig. 4, the time course of anisotropy loss due to
FproFIX19 release can be satisfactorily fit to a single exponen-
tial decay curve, which allows us to determine the off rate
constants. The off rate constant for FproFIX19 release from
wild type carboxylase was found to be 6.77  0.19 	 104 s1,
whereas the rate constants for mutants varied from 3.46 
0.12 	 104 s1 for Q503R to 102  10 	 104 s1 for V502A/
P504Q (Table III). Our results suggest that these mutations
affect the propeptide binding site rather than an internal
propeptide.
The On Rate of FproCon to Carboxylase—The apparent Kd
and off rate data suggest that these mutations may also affect
the association rate of propeptide and carboxylase (Table IV).
Therefore, we measured the association rate of FproCon to
carboxylase. As shown in Fig. 5 and Table IV, the association
rate constants for FproCon binding to wild type or mutant
enzymes varied from 1.3 	 104 to 1.2 	 105 s1 M1.
Kinetics with a Propeptide-containing Substrate—We chose
four mutations exhibiting the greatest difference in propeptide
binding kinetic properties for additional studies. The kinetic
parameters of FIX Q/S were consistent with a change in affinity
of the carboxylase for propeptide. The Km and Vmax values for
wild type are 68  6 nM and 23.4  0.6 pmol of 14CO2 per pmol
of active enzyme/h, respectively. The Km values for V502A,
Q503R, S510A, and W512A varied from 41  2 to 560  20 nM,
and the Vmax varied from 18.0  0.6 to 55.8  1.2 pmol of
14CO2/pmol of active enzyme/min (Table V and Fig. 6).
DISCUSSION
Peptide substrates bind to the vitamin K-dependent -glu-
tamyl carboxylase through their propeptide. This propeptide
binds to a specific region of the carboxylase and positions the
substrate’s glutamic acids, destined for modification, into the
active site of the enzyme. Price and Williamson observed that
residues 495–513 of human and bovine carboxylase had homol-
ogy to the propeptide of matrix Gla protein (17). They proposed
TABLE II
Comparison of kinetic parameters for FLEEL
Enzyme
FLEEL without proFIX19 FLEEL with saturating proFIX19
Km Vmax Km Vmax
mM pmol 14CO2/min/pmol enzyme mM pmol
14CO2/min/pmol enzyme
Wild type 3.3  0.4 17.0  2.6 0.78  0.12 50.4  1.7
P495V/Q497A 3.8  0.3 16.3  2.0 0.82  0.07 48.0  2.6
F496A 3.6  0.2 17.5  3.0 0.84  0.09 48.2  2.0
V502A 8.0  0.1 16.5  0.8 0.79  0.07 49.6  1.2
V502A/P504Q 7.6  0.7 16.5  2.1 0.80  0.16 48.7  2.9
Q503N 4.7  0.4 15.6  1.5 0.79  0.04 46.0  2.6
Q503R 1.9  0.2 17.2  2.5 0.78  0.11 51.8  3.7
P504Q 3.4  0.3 16.5  3.5 0.79  0.13 48.6  3.3
S510A 30 8.1  0.8 0.93  0.08 47.4  1.1
W512A 3.2  0.2 2.0  0.2 0.76  0.06 38.2  2.8
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that this propeptide-like sequence or “internal propeptide”
could react intramolecularly with the propeptide binding site of
carboxylase and thus block the active site of the enzyme. An
authentic substrate with a propeptide would displace the in-
ternal propeptide and allow the reaction to proceed. This would
prevent the promiscuous modification of glutamates of sub-
strates lacking a propeptide. Based on this model, we imagined
that equilibrium between closed (the less active) and open (the
more active) forms of carboxylase exist and that a shift toward
the open form would occur in the presence of a propeptide or a
propeptide-containing substrate. According to this hypothesis,
shifting the equilibrium toward the closed form, thus making
the internal propeptide bind tighter to the propeptide binding
site, should produce a carboxylase with lower apparent affinity
for the propeptide. Conversely, reducing the affinity of the
internal propeptide for the propeptide binding site should re-
sult in a carboxylase molecule that has a higher apparent
affinity for the propeptide.
To test this model, we made mutant carboxylases with
changes in the putative internal propeptide that we predicted
would either increase or decrease the apparent affinity of car-
boxylase for the propeptide. We were aided in the design of our
experiments by results from our previous studies in which we
demonstrated that a peptide with the consensus sequence con-
taining the most prevalent amino acid at each position in the
known propeptides binds to the carboxylase with subnanomo-
lar affinity. Therefore, we expressed five different mutant car-
boxylase molecules, F496A, V502A, Q503R, Q503N, and
P504Q. Each mutation was intended to make the enzyme’s
putative internal propeptide more or less like the consensus
propeptide sequence. Phe496 would correspond to residue 16,
and the change from the consensus phenylalanine to alanine
should reduce the affinity of the proposed internal propeptide
for the propeptide binding site. On the other hand, Val502
corresponds to position 10, and the change to alanine, the
consensus residue, should increase the affinity of the proposed
internal propeptide for the propeptide binding site. While not
highly conserved in propeptides, the most prevalent amino acid
at 9 is asparagine. In the “internal propeptide,” the corre-
sponding position is glutamine 503. Based on our studies with
the factor IX propeptide and on substitution studies done on
the human prothrombin propeptide, changing Gln503 to Arg
(16) should reduce the affinity of the putative internal propep-
tide for the propeptide binding site. Changing Gln503 to Asn,
the consensus residue might cause a modest increase in the
apparent affinity. Pro504 corresponds to position 8, which is
not a highly conserved position; however, the propeptide may
FIG. 4. Measurements of dissociation rates of proFIX19 from
wild type (a), V502A (b), and Q503R (c). Fluorescein-labeled pro-
FIX19 was preincubated with wild type or mutant carboxylase to reach
a measurable anisotropy value. A 350-fold excess of unlabeled proFIX19
was then added to compete for the propeptide binding site. Off rates
were determined by measuring the anisotropy decrease over time. Rate
constants were determined by fitting data to a single exponential decay
equation. Experiments were done at 4.5 °C.
TABLE III
Comparison of the dissociation rate constants of wild type and
mutant carboxylase
Enzyme Off rate constant Difference
104 s1 -fold
Wild type 6.77  0.19 1.0
P495V/Q497A 7.76  0.24 1.1
F496A 7.57  0.22 1.1
V502A 96.5  14.0 14.2
V502A/P504Q 102  10 15.1
Q503N 21.9  1.7 3.2
Q503R 3.46  0.12 0.5
P504Q 16.7  0.1 2.5
S510A 94.9  6.6 14.0
W512A 39.5  3.7 5.8
TABLE IV
Comparison of the association rate constants of wild type and
mutant carboxylase
Each rate constant represents the average of two measurements.
Enzyme On rate constant Difference
104 s1 M1 -fold
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have an -helical structure (25), and, if this is the case, the
proline might disrupt the helix. Therefore, changing proline
504 to the consensus sequence residue, glutamine, should in-
crease the affinity of the internal propeptide for its binding site.
To measure the relative affinity of the carboxylase molecules
for proFIX19, we determined the apparent Kd for proFIX19. As
expected, V502A and Q503N have lower affinities for proFIX19
than does wild type carboxylase. This result was consistent
with the hypothesis that residues 495–513 are functioning as
an internal propeptide. Also consistent with the hypothesis,
Q503R caused a slight decrease in the apparent Kd for pro-
FIX19. P504Q caused only a small increase in the Kd for pro-
FIX19. In contrast, F496A, which corresponds to the most
highly conserved residue in the propeptide, should have de-
creased the apparent affinity for propeptide but had no effect.
Our results then were not completely consistent with the idea
that residues 495–513 are acting as an internal propeptide.
Furthermore, our results could be interpreted to support an
alternative hypothesis (i.e. residues 495–513 are part of a
propeptide binding site). In addition, this possibility is consist-
ent with our previous report that the propeptide binding site
resides within a 14-kDa cyanogen bromide fragment beyond
residue 438.
At this point in our study, we shifted focus to distinguishing
between the two hypotheses. We reasoned that, if we mutated
residues within an internal propeptide, once a propeptide
bound to the carboxylase, its dissociation rate should be unaf-
fected by mutations at the site. This, of course, would be con-
tingent on the mutation not causing a gross conformational
change in the enzyme. If, on the other hand, we mutated
residues within the propeptide binding site, the off rates should
change in parallel with the apparent Kd for proFIX19. The
propeptide dissociation rates from the five mutant carboxylases
described above were consistent with the alternative hypothe-
sis that these residues participate in propeptide binding (Table
III and Fig. 4).
To further characterize this site, we made additional mutant
carboxylases to test the effect on propeptide binding (Table I
and Fig. 2): P495V/Q497A, V502A/P504Q, S510A, and W512A.
The double mutation P495V/Q497A had no significant effect on
any measured parameter. The double mutant V502A/P504Q
caused a 6-fold increase in the apparent Kd for proFIX19. This
effect could be attributed, predominantly, to the single point
mutation, V502A, described above. Mutation of tryptophan 512
and serine 510 both caused a greater than 200-fold increase in
the apparent Kd for proFIX19. In all cases, the apparent affin-
FIG. 5. Measurements of association rates of FproCon to wild type (a), V502A (b), S510A (c), and W512A (d). Reactions were performed
at 4.5 °C as described under “Experimental Procedures.”
TABLE V
Kinetic parameters for FIX Q/S carboxylation
Enzyme Km Difference Vmax Difference
nM -fold pmol 14CO2/h/pmol enzyme -fold
Wild type 68  6 1 23.4  0.6 1
V502A 232  16 3.4 53.4  1.8 2.3
Q503R 41  2 0.6 18.0  0.6 0.8
S510A 560  20 8.2 55.8  1.2 2.4
W512A 328  21 4.8 46.2  1.8 2.0
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ities and off rate results were consistent and supported the
propeptide binding site model. Whereas the apparent affinities
for proFIX19 and off rate data are qualitatively consistent in all
cases, the differences in the apparent Kd determined by stim-
ulation of FLEEL carboxylation are higher relative to wild type
than the differences in off rates for S510A and W512A (Table
VI). This implies that these mutations affect the association
rate of the propeptide for carboxylase. The affinities of S510A
and W512A were so low that we could not measure the on rates
using the proFIX19, so we used the consensus propeptide for
these measurements. Results shown in Table IV and Fig. 5
indicate that the on rates for S510A and W512A are indeed
about 10-fold slower than that of the wild type enzyme.
We have shown that another affect of altered propeptide
affinity is on the overall rate of carboxylation of propeptide-
containing substrates. The rate is at least partially dependent
upon the affinity of the propeptide for the carboxylase (13, 26).
In other words, product release appears to be the rate-deter-
mining step. Therefore, substrates whose propeptides have
relatively low affinities for the carboxylase have increased
rates of turnover. Conversely, substrates with high affinity for
the carboxylase exhibit slower turnover rates. Thus, we ex-
pected mutations that reduced the affinity of the carboxylase
for the propeptides to increase the Vmax (i.e. incorporation of
CO2 into a propeptide-containing substrate would be expected
to increase in the mutations with higher off rates, and a car-
boxylase with higher affinity toward the propeptide should
exhibit a lower Vmax). In contrast, in the intramolecular inter-
action model, the proposed internal propeptide sequence would
be a competitive inhibitor. In this case, we would expect
changes in Km for propeptide-containing substrate rather than
in Vmax when the mutations were made at this region. Again,
our results agree with our predictions and are consistent with
these residues being involved in propeptide binding (Fig. 6 and
Table V).
Although our kinetic studies with the small pentapeptide
FLEEL do not shed light directly on the issue of whether the
residues we mutated are involved in propeptide binding, they
are of interest for two reasons. First they show that in most
cases the mutations specifically affect propeptide binding, and
second the mutations that do affect catalysis are of interest in
terms of linkage between the substrate binding site and the
propeptide binding site. Knobloch and Suttie reported that the
propeptide of factor X stimulates CO2 incorporation into
FLEEL and suggested that this was due to such a linkage
phenomenon (12, 14, 27). We predicted, based on this hypoth-
esis, that mutation of certain propeptide binding residues will
affect the interaction of carboxylase with non-propeptide-con-
taining substrates. Conversely, certain mutations at the sub-
strate-binding site may affect propeptide binding. In fact, while
our results overwhelmingly indicate that the residues mutated
in this study are important for propeptide binding, in the
absence of proFIX19, the Km for FLEEL for V502A is higher
than that of the wild type enzyme. Additionally, both the Km
and Vmax for S510A are affected, whereas the Vmax for W512A
is significantly lower than that of wild type (Fig. 3 and Table
II). Q503R has a slightly lower Km than that of wild type. Thus,
we have found mutations that not only affect propeptide bind-
ing but also increase or decrease the catalytic efficiency of the
carboxylase toward FLEEL. Moreover, the observed catalytic
differences of the mutant carboxylases disappear in the pres-
ence of propeptide (Fig. 3 and Table II). Therefore, it is likely
that binding of the propeptide to its binding site results in a
conformational change, which alters the affinity of the small-
substrate binding site. This conclusion is consistent with our
previous result describing a residue involved in small substrate
binding (L394R), mutation of which affects propeptide binding
(19).
Since we used stimulation of FLEEL carboxylation as one
measure of propeptide affinity, this linkage may affect the
apparent Kd values we report, especially for S510A, which has
a Km at least 10 times that of wild type. Whereas our off rate,
on rate, and FIX Q/S kinetic results all support the idea that
the residues in our study are important in propeptide binding,
we assessed linkage effects by measuring the apparent Kd
values for S510A, V502A, and wild type carboxylase at higher
FLEEL concentrations. The largest effect was on the apparent
Kd for S510A that was about 3-fold lower when we performed
the experiments with 60 mM FLEEL as compared with 1.25 mM
FLEEL (results not shown). Under these conditions, the Kd of
S510A was still 100-fold higher than that of wild type carbox-
ylase; therefore, linkage effects do not affect our conclusions.
In summary, our results support the conclusion that residues
495–513 in human carboxylase do not represent an internal
propeptide involved in control of substrate binding but rather
are part of the enzyme that binds the substrates’ propeptide
directly. In addition, some of these residues are important for
functional linkage of the propeptide binding site to the sub-
strate Gla domain binding site.
FIG. 6. Carboxylation of FIX Q/S. Carboxylation of FIX Q/S by wild
type enzyme (), V502A (E), Q503R (f), S510A (Œ), or W512A (‚) was
performed at 20 °C for 1 h as described under “Experimental Proce-
dures.” The concentrations of FIX Q/S varied from 0 to 2500 nM.
TABLE VI
Comparison of the apparent Kd for proFIX19, kinetic parameters for FLEEL, off rates, and kinetic parameters for FIX Q/S
Enzyme Apparent Kd for proFIX19 Vmax/km for FLEEL carboxylation
a Off rate 	 104 Vmax for FIX Q/S carboxylation
nM pmol 14CO2/min/pmol enzyme/mM s
1 pmol 14CO2/h/pmol enzyme
Wild type 7.3  0.5 64.6  2.2 6.8  0.2 23.4  0.6
V502A 53.7  3.1 62.8  1.6 96.5  14.0 53.4  1.8
Q503R 4.2  0.1 66.4  4.7 3.5  0.1 18.0  0.6
S510A 2200  50 51.5  1.2 94.9  6.6 55.8  1.2
W512A 1770  58 50.3  3.7 39.5  3.7 46.2  1.8
a In the presence of saturating proFIX19.
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